T-cell Engagers for Autoimmune Disease: Ken Song on The Long Run - TimmermanReport.com

Ken Song is today’s guest on The Long Run. First things first, this episode was recorded before news broke that Candid Therapeutics went public via a reverse merger with RallyBio. But I must say, that...

timmermanreport.com

Next Stop: Kilimanjaro 2026 for Damon Runyon Cancer Research - TimmermanReport.com

The biotech industry can do amazing things when concentrated on an audacious goal. Like curing cancer. I’m fired up to announce the next Timmerman Traverse for Damon Runyon Cancer Research Foundation....

timmermanreport.com

Timmerman Traverse for Life Science Cares Raises Another $1.1M to Fight Poverty in 2025 - TimmermanReport.com

Another Timmerman Traverse for Life Science Cares is in the books. This year, we raised $1.15 million from more than 1,000 donors to fight poverty in biotech hubs around the US. We raised awareness of...

timmermanreport.com

CAR-T Cells Against Solid Tumors: Sabah Oney on The Long Run - TimmermanReport.com

Sabah Oney is today’s guest on The Long Run. Sabah is the CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics. This startup is developing engineered CAR-T cell therapies for solid tum...

timmermanreport.com

VIDEO: Phil Sharp and Bill Haney on 'Cracking the Code' - TimmermanReport.com

Science and society have always had an uneasy relationship. Yet there are always people out there seeking to build bridges of understanding.  I recently moderated a conversation at MIT with Phil Sharp...

timmermanreport.com

Creative Ways to Back Young Scientists: Andy Rachleff and Yung Lie on The Long Run - TimmermanReport.com

Yung Lie and Andy Rachleff are today’s guests on The Long Run. Yung is the president and CEO of the Damon Runyon Cancer Research Foundation, based in New York. Andy is the board chair. Andy was one of...

timmermanreport.com

Thank you to the sponsors of the 2025 Timmerman Traverse to Everest Base Camp!

YouTube video by Damon Runyon Cancer Research Foundation

youtube.com

Finding Therapies in Long Non-Coding RNA: John Rinn on The Long Run - TimmermanReport.com

John Rinn is today’s guest on The Long Run. John is the Leslie Orgel and Marvin Caruthers professor of RNA science at the University of Colorado in Boulder. His research is focused on long non-coding ...

timmermanreport.com

BIO International Convention | Storytelling Stage

Experience powerful stories from researchers, patients, and innovators at the BIO 2025 Storytelling Stage, June 16–19 in Boston.

convention.bio.org

Request an Invitation to the Timmerman Traverse - TimmermanReport.com

Timmerman Traverse is looking for a few good men and women. Opportunities are here for people who are physically fit, enjoy nature, thrive in community, and who want to roll up the sleeves for worthy ...

timmermanreport.com

A New and Old Idea for Cardiovascular Disease & Diabetes: Ethan Weiss & Josh Lehrer on The Long Run - TimmermanReport.com

Ethan Weiss and Josh Lehrer are today’s guests on The Long Run. Ethan is the co-founder and chief scientific officer of South San Francisco-based Marea Biosciences. Josh is the CEO. They are seeking t...

timmermanreport.com

Biologic Drug Discovery Made Faster: Peyton Greenside on The Long Run - TimmermanReport.com

Peyton Greenside is today’s guest on The Long Run. Peyton is the co-founder and CEO of San Mateo, Calif.-based BigHat Biosciences. The company was started in 2019 to build on advances in synthetic bio...

timmermanreport.com

A Sublime Experience: Views of Timmerman Traverse for Damon Runyon Cancer Research - TimmermanReport.com

Kathmandu, Nepal We did it together. The Timmerman Traverse for Damon Runyon Cancer Research Foundation completed a splendid expedition to Everest Base Camp on Apr. 23, 2025. This trip succeeded on ev...

timmermanreport.com

Nobel laureate: I owe America my success. Today, its scientific future is in danger | CNN

Dr. Ardem Patapoutian says he watches “with deep sadness as the United States’ remarkable scientific enterprise, which took generations of hard work and national investment to build, faces a concerted...

cnn.com

We Need an mRNA Champion in a Red Cape - TimmermanReport.com

I grew up in an era of Superman comic books. Superman captivated the imagination of a generation of kids like me. It told stories of an otherwise ordinary human who could achieve extraordinary feats o...

timmermanreport.com

Meet the Timmerman Traverse for Life Science Cares 2025 Team - TimmermanReport.com

The 5th annual Timmerman Traverse for Life Science Cares is fired up and ready for outdoor adventure in 2025. We’re on a mission to raise $1 million to fight poverty.  This year’s team is preparing fo...

timmermanreport.com

Timmerman Traverse for Damon Runyon Hits $700K Goal, Fueling Cancer Research - TimmermanReport.com

Times are tough in biotech, but this is an industry where we learn, adapt, and move forward. I’m proud to announce that the 2025 Timmerman Traverse for Damon Runyon Cancer Research Foundation has hit ...

timmermanreport.com

Longevity Is Having A Moment - TimmermanReport.com

Dying, with few exceptions, has never been especially popular, and our shared interest in not dying hardly constitutes breaking news.  Nevertheless, the aspiration of living longer — and remaining hea...

timmermanreport.com

A Moment of Peril and Promise - TimmermanReport.com

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, a...

timmermanreport.com

The State of Possible Conference - MassBio

Join industry leaders at the State of Possible Conference 2025 on March 26, hosted by MassBio in Boston. Discover insights on the future of biotech, pharma, and innovation in the Massachusetts life sc...

massbio.org